Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Flynn James E | Director, 10% Owner | 13 | $15.00M | $0 | 2025-01-27 |
| Mukai Takeo | Interim CFO | 8 | $0 | $0 | 2024-03-01 |
| Sohn Tom | SVP, Gen. Counsel & Secretary | 17 | $0 | $0 | 2024-02-06 |
| Mathews Kevin | SVP, Global Sales | 13 | $0 | $0 | 2024-01-07 |
| Roman David | President & CEO | 18 | $0 | $0 | 2024-01-07 |
| Marzouk Shaden | Director | 8 | $0 | $0 | 2023-06-15 |
| ElBardissi Andrew | Director | 10 | $0 | $0 | 2023-06-15 |
| Garland Jason K | Director | 4 | $0 | $0 | 2023-06-15 |
| Pellegrini Niamh Louise | Director | 6 | $0 | $0 | 2023-06-15 |
| Bonita David P | Director, 10% Owner | 21 | $22.47M | $0 | 2023-06-15 |
| Huennekens R Scott | Director | 7 | $0 | $34.8K | 2023-06-15 |
| Sheridan John F | Director | 6 | $0 | $0 | 2023-06-15 |
| Piscitello Charlie | SVP, Chief People Officer | 13 | $0 | $0 | 2023-04-01 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | Director, 10% Owner | 2 | $0 | $0 | 2022-06-30 |
| Cramp Daniella | Director | 4 | $0 | $0 | 2022-06-16 |
| Hinrichs James F. | Director | 8 | $331.2K | $0 | 2022-06-16 |
| McQuillan Steven | SVP, Clinical Affairs & QA | 6 | $0 | $0 | 2022-04-01 |
| Burgess Vincent J | Chief Executive Officer | 6 | $0 | $0 | 2022-04-01 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 13 | $22.47M | $0 | 2021-07-19 |
| Malik Shahzad | Director | 14 | $0 | $0 | 2021-06-17 |
| Barnickel John | Chief Commercial Officer | 3 | $131.4K | $0 | 2020-08-10 |
| Deerfield Private Design Fund III, L.P. | Director, 10% Owner | 12 | $27.00M | $0 | 2020-08-10 |
| Doherty Gary W. | Chief Financial Officer | 2 | $0 | $0 | 2020-08-05 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Flynn James E | Director | D To issuer deriv | 2025-01-27 | 2025-01-28 | 193,002 | — | $0 | 0 | SEC↗ |
| Flynn James E | Director | D To issuer deriv | 2025-01-27 | 2025-01-28 | 31,116 | — | $0 | 0 | SEC↗ |
| Flynn James E | Director | D To issuer deriv | 2025-01-27 | 2025-01-28 | 1,889,509 | — | $0 | 0 | SEC↗ |
| Flynn James E | Director | D To issuer deriv | 2025-01-27 | 2025-01-28 | 209,996 | — | $0 | 0 | SEC↗ |
| Flynn James E | Director | D To issuer deriv | 2025-01-27 | 2025-01-28 | 1,889,509 | — | $0 | 0 | SEC↗ |
| Mukai Takeo | CFO | F Tax w/h | 2024-03-01 | 2024-03-04 | 8,475 | $0.21 | $1.8K | 72,874 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | F Tax w/h | 2024-02-06 | 2024-02-07 | 7,582 | $0.17 | $1.3K | 105,009 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | F Tax w/h | 2024-02-01 | 2024-02-02 | 5,709 | $0.19 | $1.1K | 112,591 | SEC↗ |
| Mukai Takeo | CFO | F Tax w/h | 2024-02-01 | 2024-02-02 | 2,869 | $0.19 | $545 | 81,349 | SEC↗ |
| Roman David | President & CEO | F Tax w/h | 2024-01-07 | 2024-01-18 | 24,086 | $0.19 | $4.6K | 332,134 | SEC↗ |
| Mathews Kevin | SVP, Commercial | F Tax w/h | 2024-01-07 | 2024-01-18 | 6,342 | $0.19 | $1.2K | 61,106 | SEC↗ |
| Mukai Takeo | CFO | F Tax w/h | 2023-09-01 | 2023-09-05 | 1,729 | $0.49 | $847 | 84,218 | SEC↗ |
| Mathews Kevin | SVP, Commercial | F Tax w/h | 2023-08-05 | 2023-08-07 | 134 | $0.69 | $92 | 67,448 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | F Tax w/h | 2023-08-05 | 2023-08-07 | 433 | $0.69 | $299 | 118,300 | SEC↗ |
| Mukai Takeo | CFO | F Tax w/h | 2023-08-02 | 2023-08-02 | 501 | — | $0 | 83,447 | SEC↗ |
| Roman David | President & CEO | F Tax w/h | 2023-08-01 | 2023-08-02 | 6,484 | — | $0 | 356,220 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | A Award | 2023-08-01 | 2023-08-02 | 20,000 | — | $0 | 118,733 | SEC↗ |
| Pellegrini Niamh Louise | Director | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Garland Jason K | Director | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| ElBardissi Andrew | Director | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Huennekens R Scott | Director | A Award deriv | 2023-06-15 | 2023-06-15 | 25,480 | — | $0 | 25,480 | SEC↗ |
| Bonita David P | Director | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Sheridan John F | Director | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Marzouk Shaden | Director | A Award deriv | 2023-06-15 | 2023-06-15 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Flynn James E | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 19,600 | — | $0 | 19,600 | SEC↗ |
| ElBardissi Andrew | Director | A Award deriv | 2023-06-15 | 2023-06-29 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Pellegrini Niamh Louise | Director | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 20,972 | SEC↗ |
| Garland Jason K | Director | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 22,400 | SEC↗ |
| ElBardissi Andrew | Director | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 20,822 | SEC↗ |
| Huennekens R Scott | Director | A Award | 2023-06-15 | 2023-06-15 | 10,920 | — | $0 | 21,840 | SEC↗ |
| Bonita David P | Director | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 20,822 | SEC↗ |
| Sheridan John F | Director | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 24,347 | SEC↗ |
| Marzouk Shaden | Director | A Award | 2023-06-15 | 2023-06-15 | 8,400 | — | $0 | 20,822 | SEC↗ |
| Flynn James E | Director | A Award | 2023-06-15 | 2023-06-20 | 8,400 | — | $0 | 20,822 | SEC↗ |
| ElBardissi Andrew | Director | A Award | 2023-06-15 | 2023-06-29 | 8,400 | — | $0 | 20,822 | SEC↗ |
| Roman David | President & CEO | F Tax w/h | 2023-06-01 | 2023-06-01 | 17,290 | $0.85 | $14.7K | 362,704 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | F Tax w/h | 2023-04-01 | 2023-04-04 | 855 | $0.75 | $641 | 98,733 | SEC↗ |
| Piscitello Charlie | SVP, Chief People Officer | F Tax w/h | 2023-04-01 | 2023-04-04 | 855 | $0.75 | $641 | 85,683 | SEC↗ |
| Roman David | President & CEO | F Tax w/h | 2023-04-01 | 2023-04-04 | 3,165 | $0.75 | $2.4K | 379,994 | SEC↗ |
| Mathews Kevin | SVP, Commercial | F Tax w/h | 2023-04-01 | 2023-04-04 | 321 | $0.75 | $241 | 66,332 | SEC↗ |
| Piscitello Charlie | SVP, Chief People Officer | A Award deriv | 2023-03-01 | 2023-03-02 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Mukai Takeo | CFO | A Award deriv | 2023-03-01 | 2023-03-02 | 47,500 | — | $0 | 47,500 | SEC↗ |
| Roman David | President & CEO | A Award deriv | 2023-03-01 | 2023-03-02 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Mathews Kevin | SVP, Commercial | A Award deriv | 2023-03-01 | 2023-03-02 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | A Award deriv | 2023-03-01 | 2023-03-02 | 42,500 | — | $0 | 42,500 | SEC↗ |
| Piscitello Charlie | SVP, Chief People Officer | A Award | 2023-03-01 | 2023-03-02 | 42,500 | — | $0 | 86,538 | SEC↗ |
| Mukai Takeo | CFO | A Award | 2023-03-01 | 2023-03-02 | 47,500 | — | $0 | 83,948 | SEC↗ |
| Roman David | President & CEO | A Award | 2023-03-01 | 2023-03-02 | 135,000 | — | $0 | 383,159 | SEC↗ |
| Mathews Kevin | SVP, Commercial | A Award | 2023-03-01 | 2023-03-02 | 42,500 | — | $0 | 66,653 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | A Award | 2023-03-01 | 2023-03-02 | 42,500 | — | $0 | 99,588 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | F Tax w/h | 2023-02-01 | 2023-02-02 | 6,525 | $1.87 | $12.2K | 57,190 | SEC↗ |
| Mathews Kevin | SVP, Commercial | F Tax w/h | 2023-02-01 | 2023-02-02 | 3,540 | $1.87 | $6.6K | 24,153 | SEC↗ |
| Piscitello Charlie | SVP, Chief People Officer | F Tax w/h | 2023-02-01 | 2023-02-02 | 6,627 | $1.87 | $12.4K | 44,038 | SEC↗ |
| Roman David | President & CEO | F Tax w/h | 2023-02-01 | 2023-02-02 | 10,196 | $1.87 | $19.1K | 248,159 | SEC↗ |
| Mukai Takeo | CFO | F Tax w/h | 2023-02-01 | 2023-02-02 | 2,855 | $1.87 | $5.3K | 36,448 | SEC↗ |
| Huennekens R Scott | Director | A Award deriv | 2022-10-01 | 2022-10-11 | 5,880 | — | $0 | 5,880 | SEC↗ |
| Huennekens R Scott | Director | A Award | 2022-10-01 | 2022-10-11 | 2,520 | — | $0 | 10,920 | SEC↗ |
| Garland Jason K | Director | A Award deriv | 2022-09-01 | 2022-09-02 | 32,500 | — | $0 | 32,500 | SEC↗ |
| Mukai Takeo | Interim CFO | A Award | 2022-09-01 | 2022-09-02 | 20,000 | — | $0 | 39,303 | SEC↗ |
| Garland Jason K | Director | A Award | 2022-09-01 | 2022-09-02 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Mathews Kevin | SVP, Global Sales | F Tax w/h | 2022-08-05 | 2022-08-09 | 134 | $1.56 | $209 | 27,693 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | F Tax w/h | 2022-08-05 | 2022-08-09 | 433 | $1.56 | $675 | 63,613 | SEC↗ |
| Piscitello Charlie | Chief People Officer | F Tax w/h | 2022-08-05 | 2022-08-09 | 433 | $1.56 | $675 | 49,415 | SEC↗ |
| Roman David | President & CEO | A Award | 2022-08-01 | 2022-08-01 | 75,000 | — | $0 | 258,355 | SEC↗ |
| Piscitello Charlie | Chief People Officer | A Award deriv | 2022-07-25 | 2022-08-01 | 32,500 | — | $0 | 146,740 | SEC↗ |
| Piscitello Charlie | Chief People Officer | D To issuer deriv | 2022-07-25 | 2022-08-01 | 32,500 | — | $0 | 114,240 | SEC↗ |
| Piscitello Charlie | Chief People Officer | A Award deriv | 2022-07-25 | 2022-08-01 | 34,800 | — | $0 | 146,740 | SEC↗ |
| Piscitello Charlie | Chief People Officer | D To issuer deriv | 2022-07-25 | 2022-08-01 | 34,800 | — | $0 | 111,940 | SEC↗ |
| Piscitello Charlie | Chief People Officer | A Award deriv | 2022-07-25 | 2022-08-01 | 28,022 | — | $0 | 146,740 | SEC↗ |
| Piscitello Charlie | Chief People Officer | D To issuer deriv | 2022-07-25 | 2022-08-01 | 28,022 | — | $0 | 118,718 | SEC↗ |
| Piscitello Charlie | Chief People Officer | A Award deriv | 2022-07-25 | 2022-08-01 | 51,418 | — | $0 | 146,740 | SEC↗ |
| Piscitello Charlie | Chief People Officer | D To issuer deriv | 2022-07-25 | 2022-08-01 | 51,418 | — | $0 | 95,322 | SEC↗ |
| Mathews Kevin | SVP, Global Sales | A Award deriv | 2022-07-25 | 2022-08-01 | 20,000 | — | $0 | 57,050 | SEC↗ |
| Mathews Kevin | SVP, Global Sales | A Award deriv | 2022-07-25 | 2022-08-01 | 21,583 | — | $0 | 57,050 | SEC↗ |
| Mathews Kevin | SVP, Global Sales | A Award deriv | 2022-07-25 | 2022-08-01 | 15,647 | — | $0 | 57,050 | SEC↗ |
| Mathews Kevin | SVP, Global Sales | D To issuer deriv | 2022-07-25 | 2022-08-01 | 15,467 | — | $0 | 41,583 | SEC↗ |
| Mathews Kevin | SVP, Global Sales | D To issuer deriv | 2022-07-25 | 2022-08-01 | 21,583 | — | $0 | 35,467 | SEC↗ |
| Mathews Kevin | SVP, Global Sales | D To issuer deriv | 2022-07-25 | 2022-08-01 | 20,000 | — | $0 | 37,050 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | A Award deriv | 2022-07-25 | 2022-08-01 | 28,022 | — | $0 | 135,956 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | D To issuer deriv | 2022-07-25 | 2022-08-01 | 28,022 | — | $0 | 107,934 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | A Award deriv | 2022-07-25 | 2022-08-01 | 34,800 | — | $0 | 135,956 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | D To issuer deriv | 2022-07-25 | 2022-08-01 | 32,000 | — | $0 | 103,956 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | A Award deriv | 2022-07-25 | 2022-08-01 | 32,000 | — | $0 | 135,956 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | D To issuer deriv | 2022-07-25 | 2022-08-01 | 41,134 | — | $0 | 94,822 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | A Award deriv | 2022-07-25 | 2022-08-01 | 41,134 | — | $0 | 135,956 | SEC↗ |
| Sohn Tom | SVP, Gen. Counsel & Secretar | D To issuer deriv | 2022-07-25 | 2022-08-01 | 34,800 | — | $0 | 101,156 | SEC↗ |
| Roman David | President & CEO | A Award deriv | 2022-07-25 | 2022-08-01 | 50,000 | — | $0 | 127,335 | SEC↗ |
| Roman David | President & CEO | A Award deriv | 2022-07-25 | 2022-08-01 | 77,335 | — | $0 | 127,335 | SEC↗ |
| Roman David | President & CEO | D To issuer deriv | 2022-07-25 | 2022-08-01 | 50,000 | — | $0 | 77,335 | SEC↗ |
| Roman David | President & CEO | D To issuer deriv | 2022-07-25 | 2022-08-01 | 77,335 | — | $0 | 50,000 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director, 10% Owner | A Award deriv | 2022-06-30 | 2022-07-05 | 1,889,509 | — | $0 | 1,889,509 | SEC↗ |
| DEERFIELD MANAGEMENT COMPANY, | Director, 10% Owner | A Award deriv | 2022-06-30 | 2022-07-05 | 1,889,509 | — | $0 | 1,889,509 | SEC↗ |
| Flynn James E | Director | A Award deriv | 2022-06-16 | 2023-06-20 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Flynn James E | Director | A Award | 2022-06-16 | 2023-06-20 | 8,400 | — | $0 | 12,422 | SEC↗ |
| Bonita David P | Director, 10% Owner | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| ElBardissi Andrew | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Cramp Daniella | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Sheridan John F | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Pellegrini Niamh Louise | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Huennekens R Scott | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Hinrichs James F. | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Marzouk Shaden | Director | A Award deriv | 2022-06-16 | 2022-06-21 | 19,600 | — | $0 | 19,600 | SEC↗ |
| Bonita David P | Director, 10% Owner | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 12,422 | SEC↗ |
| ElBardissi Andrew | Director | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 12,422 | SEC↗ |
| Cramp Daniella | Director | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 11,623 | SEC↗ |
| Sheridan John F | Director | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 15,947 | SEC↗ |
| Pellegrini Niamh Louise | Director | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 12,572 | SEC↗ |
| Huennekens R Scott | Director | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 8,400 | SEC↗ |
| Hinrichs James F. | Director | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 61,311 | SEC↗ |
| Marzouk Shaden | Director | A Award | 2022-06-16 | 2022-06-21 | 8,400 | — | $0 | 12,422 | SEC↗ |
| Huennekens R Scott | Director | S Sale | 2022-06-03 | 2022-06-03 | 60,000 | $0.58 | $34.8K | 507,509 | SEC↗ |
| Roman David | Chief Financial Officer | A Award | 2022-06-01 | 2022-06-02 | 100,000 | — | $0 | 183,355 | SEC↗ |
| Roman David | Chief Financial Officer | F Tax w/h | 2022-04-01 | 2022-04-05 | 3,248 | $1.30 | $4.2K | 83,355 | SEC↗ |
| McQuillan Steven | SVP, Clinical Affairs & QA | F Tax w/h | 2022-04-01 | 2022-04-05 | 733 | $1.30 | $953 | 45,844 | SEC↗ |
| Burgess Vincent J | Chief Executive Officer | F Tax w/h | 2022-04-01 | 2022-04-05 | 3,896 | $1.30 | $5.1K | 61,469 | SEC↗ |
| Roman David | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| McQuillan Steven | SVP, Clinical Affairs & QA | A Award deriv | 2022-02-01 | 2022-02-03 | 32,000 | — | $0 | 32,000 | SEC↗ |
| Roman David | Chief Financial Officer | A Award | 2022-02-01 | 2022-02-03 | 50,000 | — | $0 | 86,603 | SEC↗ |
| McQuillan Steven | SVP, Clinical Affairs & QA | A Award | 2022-02-01 | 2022-02-03 | 32,000 | — | $0 | 46,577 | SEC↗ |
| Hinrichs James F. | Director | P Buy | 2021-11-15 | 2021-11-17 | 40,000 | $3.78 | $151.2K | 52,911 | SEC↗ |
| Pellegrini Niamh Louise | Director | A Award deriv | 2021-08-10 | 2021-08-12 | 15,191 | — | $0 | 15,191 | SEC↗ |
| Pellegrini Niamh Louise | Director | A Award | 2021-08-10 | 2021-08-12 | 4,172 | — | $0 | 4,172 | SEC↗ |
| Burgess Vincent J | Chief Executive Officer | F Tax w/h | 2021-08-05 | 2021-08-27 | 1,922 | $15.52 | $29.8K | 65,365 | SEC↗ |
| McQuillan Steven | SVP, Clinical Affairs & QA | F Tax w/h | 2021-08-05 | 2021-08-27 | 305 | $15.52 | $4.7K | 14,577 | SEC↗ |
| Flynn James E | Director, 10% Owner | P Buy | 2021-07-19 | 2021-07-21 | 390,836 | $14.00 | $5.47M | 1,974,638 | SEC↗ |
| Flynn James E | Director, 10% Owner | P Buy | 2021-07-19 | 2021-07-21 | 680,592 | $14.00 | $9.53M | 3,438,589 | SEC↗ |
| Bonita David P | Director, 10% Owner | P Buy | 2021-07-19 | 2021-07-21 | 357,143 | $14.00 | $5.00M | 1,677,361 | SEC↗ |
| Bonita David P | Director, 10% Owner | P Buy | 2021-07-19 | 2021-07-21 | 714,285 | $14.00 | $10.00M | 4,872,025 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2021-07-19 | 2021-07-21 | 357,143 | $14.00 | $5.00M | 1,677,361 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2021-07-19 | 2021-07-21 | 714,285 | $14.00 | $10.00M | 4,872,025 | SEC↗ |
| Flynn James E | Director, 10% Owner | A Award deriv | 2021-06-17 | 2021-09-02 | 7,022 | — | $0 | 7,022 | SEC↗ |
| Flynn James E | Director, 10% Owner | A Award | 2021-06-17 | 2021-09-02 | 1,800 | — | $0 | 4,022 | SEC↗ |
| Bonita David P | Director, 10% Owner | A Award deriv | 2021-06-17 | 2021-06-22 | 7,022 | — | $0 | 7,022 | SEC↗ |
| ElBardissi Andrew | Director | A Award deriv | 2021-06-17 | 2021-06-22 | 7,022 | — | $0 | 7,022 | SEC↗ |
| Malik Shahzad | Director | A Award deriv | 2021-06-17 | 2021-06-22 | 7,022 | — | $0 | 7,022 | SEC↗ |
| Marzouk Shaden | Director | A Award deriv | 2021-06-17 | 2021-06-22 | 7,022 | — | $0 | 7,022 | SEC↗ |
| Hinrichs James F. | Director | A Award deriv | 2021-06-17 | 2021-06-22 | 7,022 | — | $0 | 7,022 | SEC↗ |
| Bonita David P | Director, 10% Owner | A Award | 2021-06-17 | 2021-06-22 | 1,800 | — | $0 | 4,022 | SEC↗ |
| ElBardissi Andrew | Director | A Award | 2021-06-17 | 2021-06-22 | 1,800 | — | $0 | 4,022 | SEC↗ |
| Malik Shahzad | Director | A Award | 2021-06-17 | 2021-06-22 | 1,800 | — | $0 | 4,022 | SEC↗ |
| Marzouk Shaden | Director | A Award | 2021-06-17 | 2021-06-22 | 1,800 | — | $0 | 4,022 | SEC↗ |
| Hinrichs James F. | Director | A Award | 2021-06-17 | 2021-06-22 | 1,800 | — | $0 | 12,911 | SEC↗ |
| Burgess Vincent J | Chief Executive Officer | A Award deriv | 2021-04-01 | 2021-04-02 | 158,691 | — | $0 | 158,691 | SEC↗ |
| McQuillan Steven | SVP, Clinical Affairs & QA | A Award deriv | 2021-04-01 | 2021-04-02 | 34,800 | — | $0 | 34,800 | SEC↗ |
| Roman David | Chief Financial Officer | A Award deriv | 2021-04-01 | 2021-04-02 | 77,335 | — | $0 | 77,335 | SEC↗ |
| Burgess Vincent J | Chief Executive Officer | A Award | 2021-04-01 | 2021-04-02 | 45,065 | — | $0 | 67,287 | SEC↗ |
| McQuillan Steven | SVP, Clinical Affairs & QA | A Award | 2021-04-01 | 2021-04-02 | 9,882 | — | $0 | 14,882 | SEC↗ |
| Roman David | Chief Financial Officer | A Award | 2021-04-01 | 2021-04-02 | 36,603 | — | $0 | 36,603 | SEC↗ |
| Sheridan John F | Director | A Award deriv | 2021-03-17 | 2021-03-19 | 10,882 | — | $0 | 10,882 | SEC↗ |
| Sheridan John F | Director | A Award | 2021-03-17 | 2021-03-19 | 3,147 | — | $0 | 7,547 | SEC↗ |
| Cramp Daniella | Director | A Award deriv | 2021-02-03 | 2021-02-05 | 9,972 | — | $0 | 9,972 | SEC↗ |
| Cramp Daniella | Director | A Award | 2021-02-03 | 2021-02-05 | 2,423 | — | $0 | 3,223 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 449,992 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,002,464 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 189,366 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,199,980 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 812,683 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 7,242 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 312,840 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 13,195 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 171,695 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 34,261 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 254,495 | — | $0 | 0 | SEC↗ |
| Malik Shahzad | Director | C Conversion deriv | 2020-08-10 | 2020-08-12 | 10,738 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 378,733 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,202,117 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 389,116 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 899,985 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 647,582 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 673,123 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 872,302 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 378,733 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 1,202,117 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 389,116 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 899,985 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 647,582 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 673,123 | — | $0 | 0 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion deriv | 2020-08-10 | 2020-08-12 | 872,302 | — | $0 | 0 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 1,199,980 | — | $0 | 1,199,980 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | P Buy | 2020-08-10 | 2020-08-12 | 944,444 | $18.00 | $17.00M | 1,583,802 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 1,002,464 | — | $0 | 2,202,444 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 189,366 | — | $0 | 639,358 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | P Buy | 2020-08-10 | 2020-08-12 | 555,556 | $18.00 | $10.00M | 2,758,000 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 449,992 | — | $0 | 449,992 | SEC↗ |
| Malik Shahzad | Director | C Conversion | 2020-08-10 | 2020-08-12 | 1,551,713 | — | $0 | 1,551,713 | SEC↗ |
| Malik Shahzad | Director | C Conversion | 2020-08-10 | 2020-08-12 | 65,436 | — | $0 | 65,436 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2020-08-10 | 2020-08-12 | 41,500 | $18.00 | $747.0K | 41,500 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | P Buy | 2020-08-10 | 2020-08-12 | 373,500 | $18.00 | $6.72M | 373,500 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 1,278,718 | — | $0 | 1,320,218 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 3,784,240 | — | $0 | 4,157,740 | SEC↗ |
| Bonita David P | Director, 10% Owner | P Buy | 2020-08-10 | 2020-08-12 | 373,500 | $18.00 | $6.72M | 373,500 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 1,278,718 | — | $0 | 1,320,218 | SEC↗ |
| Bonita David P | Director, 10% Owner | C Conversion | 2020-08-10 | 2020-08-12 | 3,784,240 | — | $0 | 4,157,740 | SEC↗ |
| Bonita David P | Director, 10% Owner | P Buy | 2020-08-10 | 2020-08-12 | 41,500 | $18.00 | $747.0K | 41,500 | SEC↗ |
| Hinrichs James F. | Director | P Buy | 2020-08-10 | 2020-08-12 | 10,000 | $18.00 | $180.0K | 11,111 | SEC↗ |
| Barnickel John | Chief Commercial Officer | P Buy | 2020-08-10 | 2020-08-12 | 7,300 | $18.00 | $131.4K | 13,966 | SEC↗ |
| Marzouk Shaden | Director | A Award deriv | 2020-08-05 | 2020-08-07 | 12,454 | — | $0 | 12,454 | SEC↗ |
| Malik Shahzad | Director | A Award deriv | 2020-08-05 | 2020-08-07 | 12,454 | — | $0 | 12,454 | SEC↗ |
| Hinrichs James F. | Director | A Award deriv | 2020-08-05 | 2020-08-07 | 6,227 | — | $0 | 6,227 | SEC↗ |
| Doherty Gary W. | Chief Financial Officer | A Award deriv | 2020-08-05 | 2020-08-07 | 28,022 | — | $0 | 28,022 | SEC↗ |
| Burgess Vincent J | Chief Executive Officer | A Award deriv | 2020-08-05 | 2020-08-07 | 124,542 | — | $0 | 124,542 | SEC↗ |
| Barnickel John | Chief Commercial Officer | A Award deriv | 2020-08-05 | 2020-08-07 | 153,569 | — | $0 | 153,569 | SEC↗ |
| ElBardissi Andrew | Director | A Award deriv | 2020-08-05 | 2020-08-07 | 12,454 | — | $0 | 12,454 | SEC↗ |
| Bonita David P | Director | A Award deriv | 2020-08-05 | 2020-08-07 | 12,454 | — | $0 | 12,454 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | A Award deriv | 2020-08-05 | 2020-08-12 | 12,454 | — | $0 | 12,454 | SEC↗ |
| Marzouk Shaden | Director | A Award | 2020-08-05 | 2020-08-07 | 2,222 | — | $0 | 2,222 | SEC↗ |
| Malik Shahzad | Director | A Award | 2020-08-05 | 2020-08-07 | 2,222 | — | $0 | 2,222 | SEC↗ |
| Hinrichs James F. | Director | A Award | 2020-08-05 | 2020-08-07 | 1,111 | — | $0 | 1,111 | SEC↗ |
| Doherty Gary W. | Chief Financial Officer | A Award | 2020-08-05 | 2020-08-07 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Burgess Vincent J | Chief Executive Officer | A Award | 2020-08-05 | 2020-08-07 | 22,222 | — | $0 | 22,222 | SEC↗ |
| Barnickel John | Chief Commercial Officer | A Award | 2020-08-05 | 2020-08-07 | 6,666 | — | $0 | 6,666 | SEC↗ |
| ElBardissi Andrew | Director | A Award | 2020-08-05 | 2020-08-07 | 2,222 | — | $0 | 2,222 | SEC↗ |
| Bonita David P | Director | A Award | 2020-08-05 | 2020-08-07 | 2,222 | — | $0 | 2,222 | SEC↗ |
| Deerfield Private Design Fund | Director, 10% Owner | A Award | 2020-08-05 | 2020-08-12 | 2,222 | — | $0 | 2,222 | SEC↗ |